Oral drug delivery

Skyepharma’s oral drug delivery expertise extends from formulation to process development and scale-up, and from technology transfer and regulatory affairs to commercial manufacture. We combine our breadth and depth of expertise with our range of proprietary technologies to control when and how orally administered drugs are delivered into the body.

Since the early 1990s Skyepharma’s oral drug delivery team has concentrated on the design, development and manufacturing of complex modified release formulations. A multinational team of highly-experienced and motivated scientists has used our proprietary technologies to develop multiple complex oral dosage forms which are currently marketed by our international partner companies in more than 80 countries worldwide including the US, Europe and Japan, where they have achieved in-market sales of approximately US$4bn over the last 5 years. There are still many unsolved challenges in the oral drug delivery field and Skyepharma continues to use its longstanding expertise to conceive innovative drug delivery systems to overcome them.

We welcome the opportunity to discuss new drug delivery challenges and whether our drug delivery expertise and technologies can assist you to create innovative pharmaceutical products.

Contact us if you are interested in discussing potential collaboration.
Find out more about our oral drug delivery capabilities and technologies.

Copyright 2014, Skyepharma. All Rights Reserved. Skyepharma PLC is a public limited company registered in England and Wales, registration number 0107582.
Registered office: 46-48 Grosvenor Gardens, London SW1W 0EB, United Kingdom

Contact addresses

Skyepharma PLC
46-48 Grosvenor Gardens
London
SW1W 0EB
UK

Tel: +44 207 881 0524

Fax: +44 207 881 1199

E-mail us

Skyepharma AG
Eptingerstrasse 61
4132 Muttenz
Switzerland

Tel: +41 61 467 5555

Fax: +41 61 467 5500

E-mail us

This website works best using cookies.